[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

[Asia Economy Reporter Seo So-jeong] An elderly person in their 80s died after receiving the second dose of the COVID-19 vaccine in Gwangju, prompting health authorities to investigate the causal relationship with the vaccine.


According to the Central Disease Control Headquarters, around 9 a.m. on the 12th, an individual in their 80s who received the second dose of the Pfizer vaccine at the Gwangju vaccination center showed shock symptoms and collapsed, subsequently passing away.


An official from the health authorities stated, "It was reported as a case where shock occurred during the observation period after receiving the second dose of the Pfizer vaccine, and the person died after emergency treatment. The causal relationship with the vaccine will be evaluated through an autopsy and investigation."


He added, "The investigation is being conducted promptly in Gwangju," and "Specific details about this death case can only be disclosed after the autopsy and investigation results."


According to Gwangju City, at around 9 a.m. on the same day, an 81-year-old woman, Ms. A, received the second dose of the Pfizer vaccine at the Seo-gu Vaccination Center and collapsed after showing an anaphylaxis (severe systemic allergic reaction) response within about two minutes.


An official from the health authorities said, "It has not yet been confirmed whether the death was caused by anaphylaxis."



Regarding Ms. A, who showed no adverse reactions after the first dose but exhibited suspected anaphylaxis symptoms after the second dose, Professor Jeong Jae-hoon of the Department of Preventive Medicine at Gachon University College of Medicine said, "Even if there were no adverse reactions after the first dose, anaphylaxis symptoms can appear after the second dose," adding, "The exact cause of death should be carefully examined through an autopsy and further investigation."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing